ZA913171B - 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use - Google Patents

1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use

Info

Publication number
ZA913171B
ZA913171B ZA913171A ZA913171A ZA913171B ZA 913171 B ZA913171 B ZA 913171B ZA 913171 A ZA913171 A ZA 913171A ZA 913171 A ZA913171 A ZA 913171A ZA 913171 B ZA913171 B ZA 913171B
Authority
ZA
South Africa
Prior art keywords
preparations
pharmaceutical use
benzothiazepinone
derivatives
benzothiazepinone derivatives
Prior art date
Application number
ZA913171A
Other languages
English (en)
Inventor
Aldo Salimbeni
Salimbeni Aldo
Elso Manghisi
Manghisi Elso
Saturnino Caliari
Caliari Saturnino
Francesco Fici
Fici Francesco
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of ZA913171B publication Critical patent/ZA913171B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA913171A 1990-04-27 1991-04-26 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use ZA913171B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20160A IT1240686B (it) 1990-04-27 1990-04-27 Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico

Publications (1)

Publication Number Publication Date
ZA913171B true ZA913171B (en) 1992-02-26

Family

ID=11164306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913171A ZA913171B (en) 1990-04-27 1991-04-26 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use

Country Status (20)

Country Link
US (1) US5571807A (zh)
EP (1) EP0526495A1 (zh)
JP (1) JPH05506654A (zh)
CN (1) CN1056101A (zh)
AU (1) AU645317B2 (zh)
BG (1) BG97014A (zh)
BR (1) BR9106372A (zh)
CA (1) CA2081204A1 (zh)
CS (1) CS120991A2 (zh)
FI (1) FI924756A (zh)
HU (1) HU9203326D0 (zh)
IE (1) IE71033B1 (zh)
IL (1) IL97859A0 (zh)
IN (1) IN172160B (zh)
IT (1) IT1240686B (zh)
MA (1) MA22143A1 (zh)
PT (1) PT97508A (zh)
RO (1) RO111269B1 (zh)
WO (1) WO1991017153A1 (zh)
ZA (1) ZA913171B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118292T3 (es) * 1994-09-16 1998-09-16 Orion Corp Fermion Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
US5559229A (en) * 1995-06-01 1996-09-24 Acic (Canada) Inc. Method for the manufacture of benzothiazepine
WO2006079077A2 (en) * 2005-01-20 2006-07-27 Acadia Pharmaceuticals Inc. Use of diltiazem or analogs thereof as modulators of ghrelin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
ES2038668T3 (es) * 1986-08-20 1993-08-01 Mcneilab, Inc. Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
ATE116643T1 (de) * 1989-04-28 1995-01-15 Tanabe Seiyaku Co Verfahren zur herstellung von 1,5- benzothiazepinderivaten.
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 １，５−ベンゾチアゼピン誘導体の製法

Also Published As

Publication number Publication date
IT9020160A0 (it) 1990-04-27
IL97859A0 (en) 1992-06-21
AU7695491A (en) 1991-11-27
AU645317B2 (en) 1994-01-13
IT1240686B (it) 1993-12-17
WO1991017153A1 (en) 1991-11-14
BR9106372A (pt) 1993-04-27
IT9020160A1 (it) 1991-10-27
EP0526495A1 (en) 1993-02-10
MA22143A1 (fr) 1991-12-31
CN1056101A (zh) 1991-11-13
CS120991A2 (en) 1991-12-17
RO111269B1 (ro) 1996-08-30
PT97508A (pt) 1992-01-31
IN172160B (zh) 1993-04-17
JPH05506654A (ja) 1993-09-30
IE911411A1 (en) 1991-11-06
CA2081204A1 (en) 1991-10-28
US5571807A (en) 1996-11-05
IE71033B1 (en) 1997-01-15
FI924756A0 (fi) 1992-10-20
HU9203326D0 (en) 1993-01-28
FI924756A (fi) 1992-10-20
BG97014A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NZ239476A (en) 3-amidopyrazole derivatives; medicaments and preparation thereof
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
ZA923516B (en) New thiopyranopyrrole derivatives and their preparation
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
EP0482649A3 (en) Cm-chitin derivatives and use thereof
HU00207A9 (en) Sulfonanilide derivatives and medicine
ZA926189B (en) Beta-Phenylisoserine derivatives and their preparation and use.
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
ZA932576B (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives, their preparation and their use
NZ237442A (en) 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions
ZA913171B (en) 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
IL90407A0 (en) Pharmaceutical compositions comprising 1,2-dithiol-3-thion-s-oxide derivatives,certain such new derivatives and their preparation
NZ233400A (en) 1,3-diazine derivatives and pharmaceutical compositions
GB2253851B (en) Pyridine derivatives,their preparation and pharmaceutical use
GR890300186T1 (en) N-cycloalkylaminoethylbenzamide derivatives, their synthesis and pharmaceutical preparations
ZA911649B (en) 5-phenyl-1h-pyrazol-4-propionic acid derivatives,their preparation and their use
NZ248197A (en) 21-chloro-pregnane derivatives, preparation, use, and pharmaceutical compositions thereof
NZ224728A (en) 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions
EP0466125A3 (en) Styryl compounds and their pharmaceutical use
EP0352083A3 (en) Alkenyltetrazole derivatives, their preparation and use
IL102478A0 (en) 3,4-dehydropiperidine derivatives,their preparation and pharmaceutical compositions containing them
ZA911637B (en) N-phenylglycinamide derivatives,their preparation,pharmaceutical compositions containing them and their use